Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists.

Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists. Cancer Lett. 2010 Jul 28; 293(2):240-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.